|
Molecular
Neuro-Oncology Laboratory E. Antonio Chiocca, M.D. Ph.D.
Major
Research Interest - Gene Therapy: Gene
transfer technologies and applications to disorders of the central nervous system. The
capacity to transfer a particular gene into cells of the central nervous system
is likely to provide a major technological advance in the treatment of disorders
of the central nervous system (CNS). Vectors based on genetically modified viruses
or on artificial constructs are becoming increasingly more efficient in their
capacity to deliver and express a therapeutic gene in vivo into a selected target
tissue. We have chosen experimental CNS tumors as a model to test vectors and
anticancer genes for efficiency of expression and therapeutic effectiveness. Viral
vectors based on herpes simplex virus (HSV) have been modified to shuttle in vivo
into tumor cells genes that will activate pro-drugs, induce apoptosis, or stimulate
a host immune response. We have also modified wild-type herpes virus to render
its replication selective for tumor cells, by defining human tumor complementation
groups that will allow for the growth of different mutants of the virus. Currently
active research areas include: 1) engineering more efficient "tumor-killing"
vectors, 2) finding and testing novel prodrug/ gene therapy strategies, 3) using
different classes of anticancer genes in combination, 4) correcting the genetic
defects in brain tumor cells, 5) using vector technology to deliver therapeutic
genes in animal models of peripheral nerve and spinal cord degeneration. Important
questions related to brain tumor biology can also be investigated using gene transfer
technologies. Links
|
| Neurosurgery
Clinical Units | | |